lunes, 6 de enero de 2020

Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial | BMC Pharmacology and Toxicology | Full Text

Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial | BMC Pharmacology and Toxicology | Full Text

2-Hydroxybenzylamine (2-HOBA) is a selective dicarbonyl electrophile scavenger being developed as a nutritional supplement to help protect against the development of conditions associated with dicarbonyl elect...
Authors:Lisa M. Pitchford, Patricia M. Driver, John C. Fuller Jr, Wendell S. Akers, Naji N. Abumrad, Venkataraman Amarnath, Ginger L. Milne, Sheau-Chiann Chen, Fei Ye, L. Jackson Roberts II, M. Benjamin Shoemaker, John A. Oates, John A. Rathmacher and Olivier Boutaud
Citation:BMC Pharmacology and Toxicology 2020 21:3
Content type:Research article
Published on: 

No hay comentarios: